ID   CBR4_HUMAN              Reviewed;         237 AA.
AC   Q8N4T8; Q8WTW8; Q96K93;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 3.
DT   10-MAY-2017, entry version 122.
DE   RecName: Full=Carbonyl reductase family member 4;
DE            EC=1.-.-.- {ECO:0000269|PubMed:19000905};
DE   AltName: Full=3-ketoacyl-[acyl-carrier-protein] reductase beta subunit {ECO:0000303|PubMed:25203508};
DE            Short=KAR beta subunit {ECO:0000303|PubMed:25203508};
DE   AltName: Full=3-oxoacyl-[acyl-carrier-protein] reductase;
DE            EC=1.1.1.- {ECO:0000269|PubMed:19571038, ECO:0000269|PubMed:25203508};
DE   AltName: Full=Quinone reductase CBR4 {ECO:0000305|PubMed:19000905};
DE   AltName: Full=Short chain dehydrogenase/reductase family 45C member 1;
GN   Name=CBR4; Synonyms=SDR45C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   MET-70.
RC   TISSUE=Embryo, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   MET-70.
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   MET-70.
RC   TISSUE=Duodenum, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, CATALYTIC ACTIVITY, SUBUNIT,
RP   SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=19000905; DOI=10.1016/j.bbrc.2008.11.003;
RA   Endo S., Matsunaga T., Kitade Y., Ohno S., Tajima K., El-Kabbani O.,
RA   Hara A.;
RT   "Human carbonyl reductase 4 is a mitochondrial NADPH-dependent quinone
RT   reductase.";
RL   Biochem. Biophys. Res. Commun. 377:1326-1330(2008).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, INTERACTION WITH
RP   HSD17B8, AND PATHWAY.
RX   PubMed=19571038; DOI=10.1096/fj.09-133587;
RA   Chen Z., Kastaniotis A.J., Miinalainen I.J., Rajaram V.,
RA   Wierenga R.K., Hiltunen J.K.;
RT   "17beta-Hydroxysteroid dehydrogenase type 8 and carbonyl reductase
RT   type 4 assemble as a ketoacyl reductase of human mitochondrial FAS.";
RL   FASEB J. 23:3682-3691(2009).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10] {ECO:0000244|PDB:4CQL, ECO:0000244|PDB:4CQM}
RP   X-RAY CRYSTALLOGRAPHY (2.34 ANGSTROMS) IN COMPLEX WITH NADP AND
RP   HSD17B8, FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH HSD17B8,
RP   SUBUNIT, PATHWAY, AND MUTAGENESIS OF GLY-9; ARG-12; ARG-34; SER-135;
RP   TYR-148; LYS-152; ARG-168 AND LYS-169.
RX   PubMed=25203508; DOI=10.1038/ncomms5805;
RA   Venkatesan R., Sah-Teli S.K., Awoniyi L.O., Jiang G., Prus P.,
RA   Kastaniotis A.J., Hiltunen J.K., Wierenga R.K., Chen Z.;
RT   "Insights into mitochondrial fatty acid synthesis from the structure
RT   of heterotetrameric 3-ketoacyl-ACP reductase/3R-hydroxyacyl-CoA
RT   dehydrogenase.";
RL   Nat. Commun. 5:4805-4805(2014).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-70, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: The heterotetramer with HSD17B8 has NADH-dependent 3-
CC       ketoacyl-acyl carrier protein reductase activity, and thereby
CC       plays a role in mitochondrial fatty acid biosynthesis
CC       (PubMed:19571038, PubMed:25203508). Within the heterotetramer,
CC       HSD17B8 binds NADH; CBR4 binds NADPD (PubMed:25203508). The
CC       homotetramer has NADPH-dependent quinone reductase activity
CC       (PubMed:19000905). Both homotetramer and the heterotetramer have
CC       broad substrate specificity and can reduce 9,10-
CC       phenanthrenequinone, 1,4-benzoquinone and various other o-quinones
CC       and p-quinones (in vitro) (PubMed:19000905, PubMed:19571038,
CC       PubMed:25203508). {ECO:0000269|PubMed:19000905,
CC       ECO:0000269|PubMed:19571038, ECO:0000269|PubMed:25203508}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=11 uM for NADPH (for homotetramer)
CC         {ECO:0000269|PubMed:19000905};
CC         KM=1.6 uM for 9,10-phenanthrenequinone (for homotetramer)
CC         {ECO:0000269|PubMed:19000905};
CC         KM=1.9 uM for 1,4-benzoquinone (for homotetramer)
CC         {ECO:0000269|PubMed:19000905};
CC       pH dependence:
CC         Optimum pH is 6-8 (for homotetramer).
CC         {ECO:0000269|PubMed:19000905};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000269|PubMed:19571038, ECO:0000269|PubMed:25203508}.
CC   -!- SUBUNIT: Homotetramer (in vitro) (PubMed:19000905). Heterotetramer
CC       with HSD17B8; contains two molecules each of HSD17B8 and CBR4
CC       (PubMed:19571038, PubMed:25203508). Does not form homotetramers
CC       when HSD17B8 is coexpressed, only heterotetramers (in vitro)
CC       (PubMed:25203508). {ECO:0000269|PubMed:19000905,
CC       ECO:0000269|PubMed:19571038, ECO:0000269|PubMed:25203508}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:19000905, ECO:0000269|PubMed:19571038}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8N4T8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N4T8-2; Sequence=VSP_031527;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in liver and kidney (at protein
CC       level). {ECO:0000269|PubMed:19000905}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK027337; BAB55045.1; -; mRNA.
DR   EMBL; AK291756; BAF84445.1; -; mRNA.
DR   EMBL; AL833393; CAH10582.1; -; mRNA.
DR   EMBL; AC021151; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471056; EAX04797.1; -; Genomic_DNA.
DR   EMBL; BC021973; AAH21973.1; -; mRNA.
DR   EMBL; BC033650; AAH33650.1; -; mRNA.
DR   CCDS; CCDS3812.1; -. [Q8N4T8-1]
DR   RefSeq; NP_116172.2; NM_032783.4. [Q8N4T8-1]
DR   UniGene; Hs.659311; -.
DR   PDB; 4CQL; X-ray; 2.85 A; B/C/F/G/J/K/N/O=1-237.
DR   PDB; 4CQM; X-ray; 2.34 A; B/C/F/G/J/K/N/O=1-237.
DR   PDBsum; 4CQL; -.
DR   PDBsum; 4CQM; -.
DR   ProteinModelPortal; Q8N4T8; -.
DR   SMR; Q8N4T8; -.
DR   BioGrid; 124314; 4.
DR   IntAct; Q8N4T8; 2.
DR   STRING; 9606.ENSP00000303525; -.
DR   iPTMnet; Q8N4T8; -.
DR   PhosphoSitePlus; Q8N4T8; -.
DR   BioMuta; CBR4; -.
DR   DMDM; 269849708; -.
DR   EPD; Q8N4T8; -.
DR   MaxQB; Q8N4T8; -.
DR   PaxDb; Q8N4T8; -.
DR   PeptideAtlas; Q8N4T8; -.
DR   PRIDE; Q8N4T8; -.
DR   DNASU; 84869; -.
DR   Ensembl; ENST00000306193; ENSP00000303525; ENSG00000145439. [Q8N4T8-1]
DR   Ensembl; ENST00000504480; ENSP00000427615; ENSG00000145439. [Q8N4T8-2]
DR   GeneID; 84869; -.
DR   KEGG; hsa:84869; -.
DR   UCSC; uc003iry.4; human. [Q8N4T8-1]
DR   CTD; 84869; -.
DR   GeneCards; CBR4; -.
DR   H-InvDB; HIX0004629; -.
DR   HGNC; HGNC:25891; CBR4.
DR   HPA; HPA037499; -.
DR   neXtProt; NX_Q8N4T8; -.
DR   OpenTargets; ENSG00000145439; -.
DR   PharmGKB; PA144596471; -.
DR   eggNOG; KOG1200; Eukaryota.
DR   eggNOG; COG1028; LUCA.
DR   GeneTree; ENSGT00760000118868; -.
DR   HOVERGEN; HBG002145; -.
DR   InParanoid; Q8N4T8; -.
DR   KO; K11539; -.
DR   OMA; RIWEMSE; -.
DR   OrthoDB; EOG091G0N2V; -.
DR   PhylomeDB; Q8N4T8; -.
DR   TreeFam; TF354265; -.
DR   Reactome; R-HSA-535734; Fatty acid, triacylglycerol, and ketone body metabolism.
DR   SABIO-RK; Q8N4T8; -.
DR   UniPathway; UPA00094; -.
DR   ChiTaRS; CBR4; human.
DR   GenomeRNAi; 84869; -.
DR   PRO; PR:Q8N4T8; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000145439; -.
DR   CleanEx; HS_CBR4; -.
DR   ExpressionAtlas; Q8N4T8; baseline and differential.
DR   Genevisible; Q8N4T8; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:UniProtKB.
DR   GO; GO:1990204; C:oxidoreductase complex; IMP:UniProtKB.
DR   GO; GO:0047025; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity; IMP:UniProtKB.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IDA:UniProtKB.
DR   GO; GO:0070402; F:NADPH binding; IDA:UniProtKB.
DR   GO; GO:0008753; F:NADPH dehydrogenase (quinone) activity; IDA:UniProtKB.
DR   GO; GO:0048038; F:quinone binding; IDA:UniProtKB.
DR   GO; GO:0044255; P:cellular lipid metabolic process; TAS:Reactome.
DR   GO; GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB.
DR   GO; GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:0051290; P:protein heterotetramerization; IDA:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IPI:UniProtKB.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Fatty acid biosynthesis; Fatty acid metabolism; Lipid biosynthesis;
KW   Lipid metabolism; Mitochondrion; NAD; NADP; Oxidoreductase;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    237       Carbonyl reductase family member 4.
FT                                /FTId=PRO_0000319878.
FT   NP_BIND      11     14       NADP. {ECO:0000244|PDB:4CQM,
FT                                ECO:0000269|PubMed:25203508}.
FT   NP_BIND      34     35       NADP. {ECO:0000244|PDB:4CQM,
FT                                ECO:0000269|PubMed:25203508}.
FT   NP_BIND      83     85       NADP. {ECO:0000244|PDB:4CQM,
FT                                ECO:0000269|PubMed:25203508}.
FT   NP_BIND     181    183       NADP. {ECO:0000244|PDB:4CQM,
FT                                ECO:0000269|PubMed:25203508}.
FT   ACT_SITE    148    148       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10001}.
FT   BINDING      56     56       NADP. {ECO:0000244|PDB:4CQM,
FT                                ECO:0000269|PubMed:25203508}.
FT   BINDING     135    135       Substrate. {ECO:0000305|PubMed:25203508}.
FT   BINDING     148    148       NADP. {ECO:0000244|PDB:4CQM,
FT                                ECO:0000269|PubMed:25203508}.
FT   BINDING     152    152       NADP. {ECO:0000244|PDB:4CQM,
FT                                ECO:0000269|PubMed:25203508}.
FT   SITE        169    169       Important for interaction with acyl
FT                                carrier protein (ACP).
FT                                {ECO:0000305|PubMed:25203508}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      40     40       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q91VT4}.
FT   MOD_RES      96     96       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q91VT4}.
FT   MOD_RES     195    195       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q91VT4}.
FT   VAR_SEQ     180    237       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_031527.
FT   VARIANT      70     70       L -> M (in dbSNP:rs2877380).
FT                                {ECO:0000244|PubMed:21269460,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_039049.
FT   MUTAGEN       9      9       G->S: Unable to restore growth of an
FT                                OAR1-deficient yeast mutant.
FT                                {ECO:0000269|PubMed:25203508}.
FT   MUTAGEN      12     12       R->A: Strongly reduced ability to restore
FT                                growth of an OAR1-deficient yeast mutant.
FT                                {ECO:0000269|PubMed:25203508}.
FT   MUTAGEN      34     34       R->A: Strongly reduced ability to restore
FT                                growth of an OAR1-deficient yeast mutant.
FT                                Strongly reduces NADPH-dependent
FT                                reductase activity with acetoacetyl-CoA
FT                                and 9,10-phenanthrene quinone. No effect
FT                                on NADH-dependent reductase activitites.
FT                                {ECO:0000269|PubMed:25203508}.
FT   MUTAGEN     135    135       S->A: Unable to restore growth of an
FT                                OAR1-deficient yeast mutant.
FT                                {ECO:0000269|PubMed:25203508}.
FT   MUTAGEN     148    148       Y->A: Unable to restore growth of an
FT                                OAR1-deficient yeast mutant.
FT                                {ECO:0000269|PubMed:25203508}.
FT   MUTAGEN     152    152       K->A: Unable to restore growth of an
FT                                OAR1-deficient yeast mutant. Abolishes
FT                                NADPH-dependent reductase activity with
FT                                acetoacetyl-CoA. Strongly reduces NADPH-
FT                                dependent reductase activity with 9,10-
FT                                phenanthrene quinone. No effect on NADH-
FT                                dependent reductase activitites.
FT                                {ECO:0000269|PubMed:25203508}.
FT   MUTAGEN     168    168       R->E: Strongly reduced ability to restore
FT                                growth of an OAR1-deficient yeast mutant.
FT                                Increases NADPH-dependent reductase
FT                                activity with acetoacetyl-CoA. Reduces
FT                                NADPH-dependent reductase activity with
FT                                9,10-phenanthrene quinone. No effect on
FT                                NADH-dependent reductase activitites.
FT                                {ECO:0000269|PubMed:25203508}.
FT   MUTAGEN     169    169       K->E: Unable to restore growth of an
FT                                OAR1-deficient yeast mutant. Increases
FT                                NADPH-dependent reductase activity with
FT                                acetoacetyl-CoA. Reduces NADPH-dependent
FT                                reductase activity with 9,10-phenanthrene
FT                                quinone. No effect on NADH-dependent
FT                                reductase activitites.
FT                                {ECO:0000269|PubMed:25203508}.
FT   STRAND        4      8       {ECO:0000244|PDB:4CQM}.
FT   TURN          9     11       {ECO:0000244|PDB:4CQM}.
FT   HELIX        14     23       {ECO:0000244|PDB:4CQM}.
FT   TURN         24     26       {ECO:0000244|PDB:4CQM}.
FT   STRAND       28     34       {ECO:0000244|PDB:4CQM}.
FT   HELIX        36     45       {ECO:0000244|PDB:4CQM}.
FT   STRAND       51     54       {ECO:0000244|PDB:4CQM}.
FT   HELIX        60     69       {ECO:0000244|PDB:4CQM}.
FT   TURN         70     74       {ECO:0000244|PDB:4CQM}.
FT   STRAND       77     82       {ECO:0000244|PDB:4CQM}.
FT   TURN         92     94       {ECO:0000244|PDB:4CQL}.
FT   HELIX        97    107       {ECO:0000244|PDB:4CQM}.
FT   HELIX       109    124       {ECO:0000244|PDB:4CQM}.
FT   STRAND      128    133       {ECO:0000244|PDB:4CQM}.
FT   HELIX       136    138       {ECO:0000244|PDB:4CQM}.
FT   HELIX       146    165       {ECO:0000244|PDB:4CQM}.
FT   HELIX       167    169       {ECO:0000244|PDB:4CQM}.
FT   STRAND      171    178       {ECO:0000244|PDB:4CQM}.
FT   HELIX       190    193       {ECO:0000244|PDB:4CQL}.
FT   HELIX       206    218       {ECO:0000244|PDB:4CQM}.
FT   STRAND      226    232       {ECO:0000244|PDB:4CQM}.
FT   HELIX       233    235       {ECO:0000244|PDB:4CQM}.
SQ   SEQUENCE   237 AA;  25301 MW;  376FF5FA0CB9ABF0 CRC64;
     MDKVCAVFGG SRGIGRAVAQ LMARKGYRLA VIARNLEGAK AAAGDLGGDH LAFSCDVAKE
     HDVQNTFEEL EKHLGRVNFL VNAAGINRDG LLVRTKTEDM VSQLHTNLLG SMLTCKAAMR
     TMIQQQGGSI VNVGSIVGLK GNSGQSVYSA SKGGLVGFSR ALAKEVARKK IRVNVVAPGF
     VHTDMTKDLK EEHLKKNIPL GRFGETIEVA HAVVFLLESP YITGHVLVVD GGLQLIL
//
